Average Co-Inventor Count = 9.51
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Galapagos Nv (12 from 116 patents)
2. Abbvie Inc. (9 from 822 patents)
3. Abbott Laboratories Corporation (7 from 4,177 patents)
4. Abbvie S.a.r.l. (7 from 15 patents)
5. Abbvie Overseas Sarl (5 from 5 patents)
6. Abbvie Bahamas Limited (6 patents)
28 patents:
1. 10988454 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
2. 10981890 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
3. 10844041 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
4. 10844042 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
5. 10829473 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
6. 10428017 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
7. 10399940 - Substituted pyrrolidines and methods of use
8. 10118916 - Modulators of cystic fibrosis transmembrane conductance regulator protein
9. 9981910 - Substituted pyrrolidines and methods of use
10. 9969693 - 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use
11. 9840513 - Substituted tricyclics and method of use
12. 9642831 - Substituted chromanes and method of use
13. 9567322 - Substituted tetrahydropyrans and method of use
14. 9452986 - 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use
15. 9193713 - Compounds as cannabinoid receptor ligands